Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2011
09/07/2011CN101429243B Melamine and carrier protein couplet product, preparation method and uses of melamine antibody
09/07/2011CN101348787B Preparation and use of giant panda Ascaris schroederi antigen
09/07/2011CN101307092B Method for synthesizing general artificial antigen of beta-lactam drugs
09/07/2011CN101163716B Interleukin-6 polyethylene glycol conjugate and its preparing method and use
09/07/2011CN101139383B C end modification endomorphin 2
09/07/2011CN101121747B Method for separating and purifying glutamine transaminase activation proteinase inhibitor
09/07/2011CN101037691B CENP-E combined protein and encoding gene and application
09/06/2011US8013208 Methods for producing antibodies
09/06/2011US8013135 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
09/06/2011US8013129 Protein separation device
09/06/2011US8013128 Antibodies and related molecules that bind to PSCA proteins
09/06/2011US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer
09/06/2011US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines
09/06/2011US8013120 C-reactive protein and its use to treat systemic lupus erythematosus and related conditions
09/06/2011US8013119 Fluorescent protein
09/06/2011US8013118 Lynx polypeptides
09/06/2011US8013114 Fusion proteins based upon somatostatin receptors
09/06/2011US8013113 FRET protease assays for clostridial toxins
09/06/2011US8013112 Compositions comprising human brain natriuretic peptide (BNP) fragments
09/06/2011US8012933 Use of the cathelicidin LL-37 and derivatives therof for wound healing
09/06/2011US8012932 Contraceptives based on SP22 and SP22 antibodies
09/06/2011US8012931 Modified FGF-21 polypeptides and their uses
09/06/2011US8012928 Truncated PAP2 and methods of making and using same
09/06/2011US8012748 Peripheral nervous system specific sodium channel nucleic acids
09/06/2011US8012747 Recombinant vesicular stomatitis viral vector system for delivery of interfering RNA sequences to cells; gene expression inhibition
09/06/2011US8012739 Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs
09/06/2011US8012736 Multi plasmid system for the production of influenza virus
09/06/2011US8012716 Animal protein-free medium; making and purifying botulinum toxin
09/06/2011US8012715 Methods for production of proteins
09/06/2011US8012707 MN gene and protein
09/06/2011US8012704 Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
09/06/2011US8012702 H+-gated ion channel
09/06/2011US8012701 Agonists of bitter taste receptors and uses thereof
09/06/2011US8012700 Assays for preimplantation factor and preimplantation factor peptides
09/06/2011US8012692 Elastin peptide fingerprints and analysis methods for MMP12 related to COPD
09/06/2011US8012684 Mutated AQP, method for detecting cancer using the same, DNA chip having oligonucleotides of said mutated AQP sequence
09/06/2011US8012679 Papillomavirus vaccines
09/06/2011US8012491 Recombinant toxin fragments
09/06/2011US8012490 Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
09/06/2011US8012489 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
09/06/2011US8012487 Amino acid sequence comprising immunogenic epitope cluster for use as tool in diagnosis and treatment of autoimmune disorders
09/06/2011US8012479 Recombinant toxin fragments
09/06/2011US8012476 Molecules with extended half-lives, compositions and uses thereof
09/06/2011US8012468 Dendrite cells transduced with recombinant adenovirus AdVCEA which generate CEA-specific cytotoxic T lymphocytes, vaccine and pharmaceutical composition comprising the same
09/06/2011US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders
09/06/2011CA2654733C Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
09/06/2011CA2533877C Safe mutant viral vaccines
09/06/2011CA2463085C Vaccines against arthropod-borne infectious diseases
09/06/2011CA2452260C Novel variants and exons of the glyt1 transporter
09/06/2011CA2438230C Mixture of bacilllus thuringiensis subspecies israelensis and bacillus sphaericus for management of resistance to mosquito larvicides
09/06/2011CA2427578C A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine
09/06/2011CA2335230C Regions of papilloma virus e1 helicase involved in e1 oligomerization
09/04/2011CA2695337A1 Compositions and methods for inhibition of hiv
09/01/2011WO2011106743A1 Recombinant cdv compositions and uses thereof
09/01/2011WO2011106723A2 Anti-paf antibodies
09/01/2011WO2011106681A2 SMOOTH MUSCLE-LIKE CELLS (SMLCs) DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
09/01/2011WO2011106676A2 Methods of human embryonic stem cell growth
09/01/2011WO2011106607A2 Subunit vaccines for herpes viruses and methods of use
09/01/2011WO2011106401A2 Methods and compositions relating to multiciliate cell differentiation
09/01/2011WO2011106086A1 Pegylated albumin polymers and uses thereof
09/01/2011WO2011105891A1 Combination vaccine for streptococcus
09/01/2011WO2011105841A2 Recombinant expression vector for expressing brazzein, and novel multiple mutation brazzein variant having greater sweetness
09/01/2011WO2011105648A1 Oligopeptide improving differentiation of osteoblasts
09/01/2011WO2011104684A1 Proteins/peptides having immunogenic properties and their biological applications
09/01/2011WO2011104632A1 Immunogenic proteins and compositions
09/01/2011WO2011104627A1 Metabolites of dop2-d-lys(dop2)-cyclo[cys-tyr-d-trp-lys-abu-cys]-thr-nh2
09/01/2011WO2011104379A1 Peptides for treatment of obesity
09/01/2011WO2011104378A1 Peptides for treatment of obesity
09/01/2011WO2011104309A1 Compounds for the treatment of inflammation and neutropenia
09/01/2011WO2011104284A1 Polypeptides having antimicrobial activity
09/01/2011WO2011104153A1 Nematode-resistant transgenic plants
09/01/2011WO2011104141A1 Plants having enhanced yield-related traits and a method for making the same
09/01/2011WO2011103714A1 Genes conferring stress tolerance in plants and uses thereof
09/01/2011WO2011103667A1 Agonistic antibodies to trkb receptors and uses thereof
09/01/2011WO2011103666A1 Modulation of cytokine-induced chronic inflammatory responses
09/01/2011WO2011082310A3 Methods and compositions for targeted polynucleotide modification
09/01/2011WO2011070440A3 Oncolytic rhabdovirus
09/01/2011WO2011063003A3 Peptides and methods for the detection of lyme disease antibodies
09/01/2011WO2011059329A3 Pentose transporters and uses thereof
09/01/2011WO2011036445A3 Polypeptides and uses thereof
09/01/2011US20110214209 Modified bacillus thuringiensis cry12 proteins for nematode control
09/01/2011US20110214208 Modified Bacillus Thuringiensis Cry5 Proteins For Nematode Control
09/01/2011US20110214206 Nucleic acid molecules and other molecules associated with plants
09/01/2011US20110214203 Sugar and lipid metabolism regulators in plants ii
09/01/2011US20110213293 Ligands to radiation-induced molecules
09/01/2011US20110213132 Production of ngf in plant
09/01/2011US20110213130 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
09/01/2011US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer
09/01/2011US20110212903 Metal-binding compounds and uses therefor
09/01/2011US20110212902 Metal-binding compounds and uses therefor
09/01/2011US20110212898 Chimeric peptides for the regulation of gtpases
09/01/2011US20110212897 Wnt3a for inhibition of scarring
09/01/2011US20110212896 Peptides for the treatment of oxidative stress related disorders
09/01/2011US20110212895 Treatment of Cognitive and Learning Impairment
09/01/2011US20110212889 Use of leptin for the treatment of fatty liver diseases and conditions
09/01/2011US20110212885 Ophthalmic and contact lens solutions containing peptides as preservative
09/01/2011US20110212881 Aleurone as a prebiotic fiber for improved intestinal health
09/01/2011US20110212859 Radio frequency identifiers for use in biological science
09/01/2011US20110212528 Novel substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system
09/01/2011US20110212518 Expression vector and methods of producing high levels of proteins